About Enhancer

Enhancer ID: E_01_0440
Species: human
Position : chr11:32385307-32387307
Biosample name:
Experiment class : High+Lowthroughput
Enhancer type: Enhancer
Disease: Wilms tumor 1 (wt1)
Pubmed ID:  29851165
Enhancer experiment: ChIP-seq,Quantitative methylation-specific PCR,Quantitative methylation-specific PCR,Western blot,
Enhancer experiment description: Our data suggest that the methylation pattern of the WT1 promoter and enhancers in human podocytes are distinctive from those in HK2. Furthermore, TGF-?1 alters the methylation levels of the WT1 promoter and enhancers in human podocytes. This modification may be relevant to the attenuation of WT1 by TGF-?1, which could contribute to podocyte injury.

About Target gene

Target gene : WT1(AWT1,GUD,NPHS4,WAGR,WIT-2,WT33)
Strong evidence: qRT-PCR,qPCR,ChIP,3C
Less strong evidence: RNA-Seq
Target gene experiment description: Our data suggest that the methylation pattern of the WT1 promoter and enhancers in human podocytes are distinctive from those in HK2. Furthermore, TGF-?1 alters the methylation levels of the WT1 promoter and enhancers in human podocytes. This modification may be relevant to the attenuation of WT1 by TGF-?1, which could contribute to podocyte injury.

About TF

TF name : --
TF experiment: ChIP-seq,Quantitative methylation-specific PCR,Quantitative methylation-specific PCR,Western blot,
TF experiment description: Our data suggest that the methylation pattern of the WT1 promoter and enhancers in human podocytes are distinctive from those in HK2. Furthermore, TGF-?1 alters the methylation levels of the WT1 promoter and enhancers in human podocytes. This modification may be relevant to the attenuation of WT1 by TGF-?1, which could contribute to podocyte injury.

About Function

Enhancer function : Our data suggest that the methylation pattern of the WT1 promoter and enhancers in human podocytes are distinctive from those in HK2. Furthermore, TGF-?1 alters the methylation levels of the WT1 promoter and enhancers in human podocytes. This modification may be relevant to the attenuation of WT1 by TGF-?1, which could contribute to podocyte injury.
Enhancer function experiment: Immunohistochemical staining
Enhancer function
experiment description:
Our data suggest that the methylation pattern of the WT1 promoter and enhancers in human podocytes are distinctive from those in HK2. Furthermore, TGF-?1 alters the methylation levels of the WT1 promoter and enhancers in human podocytes. This modification may be relevant to the attenuation of WT1 by TGF-?1, which could contribute to podocyte injury.

About SNP

SNP ID: --

Upstream Pathway Annotation of TF

GeneName Pathway Name Source Gene Number

Enhancer associated network

The number on yellow line represents the distance between enhancer and target gene

Expression of target genes for the enhancer


Enhancer associated SNPs